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A B S T R A C T
This study examined the factor structure of the Hungarian version of the Birchwood Insight Scale (BIS) and
analyzed its association with socio-demographics, diagnosis, internalized stigma, and shame using confirmatory
factor analysis (CFA) with covariates. Mentally ill patients (N = 200) completed self-report questionnaires. CFA
supported a two-factor structure. While previous hospitalizations and diagnosis were associated with insight,
insight predicted higher internalized stigma and shame. Efforts to increase insight should be matter of im-
portance in the wider spectrum of mental diagnoses. However, such efforts should be conducted with special
care as further research is needed to understand the impact of insight on wellbeing.
Introduction
Having insight, or awareness of having a mental illness diagnosis is
a crucial step in successful coping and recovery (Frese, 2000; McEvoy,
2004). Insight has been defined as including three different but over-
lapping dimensions: (i) individuals' acknowledgment of having a
mental illness diagnosis; (ii) the recognition that treatment is necessary
to control the illness, and (iii) the ability to re-label the experienced
symptoms as abnormal and part of the illness (David, 1990). Un-
fortunately, individuals with various different mental disorders often
possess poor insight (Ghaemi et al., 2000; Pini et al., 2001). Lack of
insight has been found to be an important predictor of adverse clinical
outcomes, treatment non-compliance, and increased cognitive impair-
ment (Aleman et al., 2006; Mohamed et al., 2009; Yen et al., 2005).
However, conflicting findings implying that having insight is not ne-
cessarily associated with positive outcomes, contribute much to the
complexity of the insight construct, and were consequently coined as
the “insight paradox” (Lysaker et al., 2007).
More specifically, it has been found that having high insight is as-
sociated with depressive symptoms, low quality of life, low self-esteem,
and less meaning in life (Ehrlich-Ben Or et al., 2013; Lysaker et al.,
2003; Mintz et al., 2003; Moore et al., 1999; Staring et al., 2009). Re-
cently this paradox was explained with the internalization of stigma, a
psychological process that occurs when individuals agree with the
stigma that is present in society, internalize the stigma, and adopt a
stigmatized identity (Corrigan et al., 2006). According to this assertion,
the meaning that is attached to the recognition of having a mental ill-
ness is important, and individuals who demonstrate high insight to-
gether with high levels of internalized stigma are more prone to ex-
perience adverse outcomes (Lysaker et al., 2007; Staring et al., 2009).
What makes insightful people adopt a stigmatized identity is a question
which was investigated by Hasson-Ohayon et al. (2012), who found
that the experience of shame mediated the relationship between insight
and internalized stigma. Therefore, shame should be regarded as an
important factor which – when accompanied by insight – affects the
susceptibility to internalization of stigma.
Over the years, efforts to assess insight have taken different ap-
proaches. Among these are the assessment of insight utilizing a one-
item measure to detect overall insight level (Lincoln et al., 2007a).
However, this is an approach which is not considered to be sensitive
enough to the specific and different dimensions of insight (Baier, 2010).
Consequently, different scales were developed in order to take into
consideration the multi-dimensional nature of insight (Amador et al.,
1993; Beck et al., 2004). However, most of the existing scales are based
on clinicians' observations (Young et al., 2003) and might also require
some training in how to administer the scales (Sanz et al., 1998).
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Furthermore, some instruments are very long, which might be an ob-
stacle for patients with limited mental and/or psychological capacities
(Cleary et al., 2014).
The Birchwood Insight Scale (BIS; Birchwood et al., 1994), is an
eight-item self-report measure, which was developed to offer an easy
and brief alternative to assess the three insight dimensions. The BIS is a
reliable and valid tool to assess insight, and is sensitive enough to assess
individual differences and changes in insight which might occur over
time (Birchwood et al., 1994). Despite being increasingly used in psy-
chiatric research (Cleary et al., 2014), very few studies have examined
the scale's psychometric properties and/or factor structure, and their
findings are inconsistent. Birchwood et al. (1994) reported on the same
three-factor structure which was previously found by David (1990).
However, other researchers have reported that a one-factor struc-
ture yielded the best fit among a sample of patients experiencing a first
episode of psychosis, and a mixed sample of chronic patients with
psychotic and mood disorders (Cleary et al., 2014). Additionally, be-
cause studies investigating insight in the psychiatric field have mainly
focused on individuals with schizophrenia and psychosis (Ghaemi,
1997), the BIS has mainly been used among these patient groups
(Cleary et al., 2014). Consequently, the generalizability of the BIS to
other patient populations is unclear. While poor insight is a main
symptom of schizophrenia and psychosis in general (Amador et al.,
1994; Carpenter et al., 1978; Pini et al., 2001), there is increasing
empirical evidence that it also occurs in many other disorders such as
bipolar disorder, mood disorders without psychotic symptoms, and
anxiety disorders (Amador et al., 1994; Eisen et al., 1998; Ghaemi et al.,
2000; Michalakeas et al., 1994; Peralta & Cuesta, 1998; Pini et al.,
2001).
The main goal of the present study was to examine the factor
structure of the BIS using a relatively large sample of patients experi-
encing a wide range of mental diagnoses. Moreover, as all the previous
studies were conducted among English-speaking populations, the pre-
sent study examined the functioning of the BIS factor structure among a
non-English speaking sample. Furthermore, the secondary goal of the
study was to examine the possible predictors of insight including socio-
demographic factors, diagnosis, and previous hospitalizations. Given
the relationship between insight and internalized stigma and the latter's
negative impact on recovery, the ability of insight to predict both in-
ternalized stigma and shame was also investigated. It was hypothesized
that a high degree of insight would be a significant predictor of high
levels of internalized stigma and shame. Due to the high prevalence of
poor insight among patients with diverse diagnoses, and its' meaningful
implications (both positive and negative) for recovery, insight con-
stitutes a major concern in the mental health field. Consequently, ac-
quiring more precise knowledge regarding the different predictors and
outcomes of insight on their different facets can meaningfully con-
tribute to the improvement of the lives of people coping with mental
illness and is of high clinical importance.
Methods
Participants
A sample of 200 adults with a mental illness diagnosis was recruited
from an outpatient unit of mental health center in the Hungarian capital
of Budapest. The inclusion criteria were: (i) having a psychiatric diag-
nosis according to the ICD-10 (World Health Organization, 1992), (ii)
taking psychiatric medications, (iii) being inpatients or outpatients in
any type of psychiatric care, (iv) being patients who had not abused
illicit substances and alcohol for at least two weeks at the time of the
assessment, (v) being aged between 18 and 65 years, and (vi) being able
to complete the questionnaire following the judgment of their psy-
chiatrist. The exclusion criteria were (i) having an acute phase of ill-
ness, (ii) having a diagnosis of an organic brain disorder, dementia,
and/or mental retardation, and (iii) not having the mental competency
and/or ability to complete the self-report questionnaire or give in-
formed consent.
Procedure
Patients who met the study inclusion criteria were contacted via
their treating psychiatrists. Upon agreement to participate, patients
received an information sheet about the study's goals and signed an
informed consent form. Participants then completed a self-report
questionnaire. All questionnaires were translated from English to
Hungarian and back-translated from Hungarian to English using ac-
cepted translation protocols (Beaton et al., 2000). The possible dis-
crepancies between the original and back-translated version were re-
solved. Ethical approval was granted by the ethical board of the
regional hospital accountable for the patients' welfare.
Measures
Socio-demographic questions included those relating to gender, age,
previous hospitalizations (yes/no), education (finished high school/did
not finish high school), occupation (employed/unemployed), diagnosis,
and marital status (married/divorce/widow/single). Patients were di-
vided into six categories according to the ICD-10 codes categorization
(World Health Organization, 1992): (i) schizophrenia spectrum dis-
orders (e.g., schizophrenia, schizotypal and delusional disorder), (ii)
mood disorders (e.g., major depressive disorder, bipolar and manic
disorder), (iii) stress-related disorders (e.g., phobic anxiety disorders,
obsessive-compulsive disorders, somatoform disorders), (iv) behavioral
syndromes associated with physiological disturbances (e.g., eating
disorders), (v) personality disorders (e.g., borderline personality dis-
order, avoidant personality disorder), and (vi) disorders due to psy-
choactive substance use.
Insight
The Birchwood Insight Scale (BIS; Birchwood et al., 1994) is an
eight-item self-report instrument that assesses three dimensions of in-
sight into mental illness (illness awareness: Items 2 and 7; need for
treatment: Items 3,4,5 and 6; and re-labeling of symptoms: Items 1 and
8). Each item contains a statement offering three response options:
agree, unsure, or disagree. Each response is scored on the basis of the
insight level it reflects, where insightful responses (agree/disagree) are
scored 2, unsure responses are scored 1, and responses which reflect
poor insight are scored 0. Because the sample of the present study in-
cluded patients who were not hospitalized, a minor change was made in
Item 4 assuming hospitalization (“My stay in the hospital is necessary”
was adapted to “The treatment in the institution is necessary”). The scale
has good internal consistency and reliability (α = 0.75 and test-retest
reliability = 0.90) (Birchwood et al., 1994). In the present study the
BIS had moderate internal consistency (α = 0.64).
Internalized stigma
The Self-Stigma of Mental Illness Scale (SSMIS; Corrigan et al.,
2006) is a self-report instrument that assesses internalization of stig-
matic views that exist in society. The scale includes four subscales re-
flecting the four stages process of stigma internalization as proposed by
Corrigan et al. (2006): (i) awareness of the existence of stigmatic views
regarding mental illness, (ii) agreement with the stigmatic views, (iii)
adopting stigmatic views and projecting them into the self-identity, and
(iv) self-esteem reduction. Each subscale contains ten statements to
which participants can respond to on a nine-point Likert scale ranging
from 1 (strongly disagree) to 9 (strongly agree). The total score of each
subscale ranges between 10 and 90, where higher scores reflect in-
creased adoption of stigma as indicated by the specific subscale. Good
internal consistency was found in the present study (stigma awareness:
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α = 0.92, stigma agreement: α = 0.90, stigma internalization:
α = 0.83 and self-esteem reduction: α = 0.84).
Shame
The Experience of Shame Scale (EES; Andrews et al., 2002) is a 25-
item instrument that assesses three aspects of shame: (i) character-
ological shame (experiencing shame because of personal habits, beha-
vior with others, the kind of person, and because of self-capabilities),
(ii) behavioral shame (experiencing shame when doing and saying
something wrong and due to failure in competitive situations), and (iii)
bodily shame (experiencing shame because an individual considers their
body or its parts unacceptable). In the assessment of each aspect, there
are three items addressing the following: (i) experimental component
(with a direct question about feeling shame), (ii) cognitive component
(such as concerns regarding the opinion of others), and (iii) behavioral
component (questions regarding efforts to hide or avoid situations). For
each item, participants are asked to respond based on their feelings over
the past year on a four-point Likert scale ranging from 1 (not at all) to 4
(very much). Scores are calculated by summing up the items to produce
a total score ranging between 25 and 100. The Hungarian validated
version of this scale (Vizin et al., 2016) was used in this study, and had
excellent reliability (α = 0.97).
Statistical analyses
First, a series of confirmatory factor analyses (CFAs) were used to
assess the factor structure and item performance of the Hungarian
version of the BIS in the sample. Unlike previous studies, items of the
Birchwood Insight Scale were treated as ordinal and used the mean- and
variance- adjusted weighted least squares (WLSMV) estimator. In CFA,
acceptable degree of fit requires the comparative fit index (CFI) and the
Tucker-Lewis Index (TLI) to be close to 0.95, and the model should be
rejected when these indices are< 0.90 (Brown, 2006). The next fit
index was root mean squared error of approximation (RMSEA). RMSEA
below 0.05 indicates excellent fit, a value around 0.08 indicates ade-
quate fit, and a value above 0.10 indicates poor fit (Browne & Cudek,
1993). The measurement invariance of the BIS was also tested in groups
having or not having a schizophrenia diagnosis. After establishing
measurement invariance, groups with different diagnosis were com-
pared for statistical differences in factor scores. Next, a CFA with cov-
ariates was performed to test the association between insight and age,
gender and previous hospitalizations, while diagnosis was controlled
for. The CFA with covariates technique was chosen for the present study
because it can best estimate the effect of indicators and grouping
variables or other continuous variables on latent variables simulta-
neously. Finally, the association between the insight factors, inter-
nalized stigma, and shame was investigated. All analyses were per-
formed with MPLUS 8.1 (Muthén & Muthén, 1998).
Results
Descriptive statistics
The percentages, means, and standard deviations (SDs) of the study
variables are shown in Table 1. The majority of the sample were
women, graduated from high school, and were diagnosed with stress-
related disorders. Almost half of the sample had previous hospitaliza-
tions. The age range of the sample was wide (32 to 56 years), with a
mean of 44.2 years (SD = 11.8).
Confirmatory factor analyses of the Birchwood Insight Scale
As a first step, the one-factor model (Model 1) was tested which
yielded excellent fit (see Table 2). However, the inspection of the factor
loadings showed that Item 1 (“Some of my symptoms are made by my
mind”) did not load significantly on this factor. The three-factor model
was also tested as suggested in previous research. This model also
yielded excellent fit (see Table 2). However, the third (“re-labeling of
symptoms”) factor has only one significantly loading item, and Item 1
did not load significantly on this factor either (see Table 3). Because of
the large correlation between “awareness of illness” and “re-label of
symptoms”, they were merged, and a two-factor model was tested with
exclusion of Item 1. This model also yielded an excellent degree of fit
(see Table 2). This two-factor model with seven items was also con-
trasted with the one-factor model with seven items. Since the two-factor
model showed superior fit to data, this model was retained in further
analysis. The factor loadings in this model ranged between 0.58 and
0.68 in the “awareness of illness factor” and between 0.44 and 0.89 in the
“need for treatment” factor. The correlation between the two factors was
strong (r = 0.75).
Because this scale was tested primarily with patients suffering from
psychosis, the measurement invariance between patients diagnosed
with schizophrenia and not diagnosed with schizophrenia was also
checked. Applying the increasing constraints did not worsen the model
fit significantly therefore the measurement invariance was supported
(see details in Table 2).
Differences of insight among patients with different diagnoses
After establishing the measurement model of insight, comparison of
patients with different diagnosis along the factor scores of two insight
dimensions was made. Fig. 1 shows the means and 95% confidence
intervals of factor score of awareness of illness and need for treatment
factors among patients with schizophrenia spectrum disorders, mood
disorders, stress-related disorders, and other disorder diagnosis (such as
personality disorders, disorders due to psychoactive substance use, and
behavioral syndrome associated with physiological disturbances). A
significant main effect was found in the awareness of illness factor (F(3,
192) = 2.86, p < 0.05). Tukey HSD post-hoc test showed that only
schizophrenia spectrum disorders and mood disorders groups differed
significantly (p < 0.03). The effect size of the difference was medium
sized (Cohen d = 0.52). Although the statistical test did not reach the
level of significance, the effect size of the group difference is not neg-
ligible. For example, the difference between schizophrenia and stress-
related groups was also medium sized (Cohen d = 0.40), and that be-
tween mood disorders and stress-related disorders group was small
(Cohen d = 0.17). In the case of the need for treatment factor, a sig-
nificant main effect was also found (F(3,192) = 5.05 p < 0.01).
However, only the group with other diagnosis differed significantly
from schizophrenia (p < 0.01), mood disorders (p < 0.01), and
stress-related disorders (p < 0.05) groups according to Tukey HSD
test.
The schizophrenia spectrum disorder patients had the highest score
for need for treatment but it differed significantly only from the other
Table 1
Descriptive statistics of the study sample (N = 200).
Gender (female) N (%) 133 (66.5)
Age – mean (SD) 44.2 (11.8)
Education, graduated high school – N (%) 157 (78.5)
Previous hospitalizations – N (%) 89 (44.5)
Diagnosis
Schizophrenia spectrum disorders – N (%) 53 (26.5)
Mood disorders – N (%) 58 (29.0)
Stress-related disorders – N (%) 89 (44.5)
Personality disorders – N (%) 10 (5.0)
Disorders due to psychoactive substance use – N (%) 2 (1.0)
Behavioral syndrome associated with physiological disturbances
– N (%)
2 (1.0)
Only one diagnosis - N (%) 188 (94.0)
Two diagnoses - N (%) 10 (5.0)
Three diagnoses - N (%) 2 (1.0)
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diagnosis group. However, the effect size of difference between schi-
zophrenia and stress-related group was not negligible either (Cohen
d = 0.35), but it did not reach statistical significance due to the low
statistical power because the required sample size would be 260 (if the
power was 0.80) in this case. The difference between schizophrenia and
mood disorder group was negligible (Cohen d = 0.09).
Predictors of insight: Gender, age and hospitalization
Table 4 presents the result of bivariate correlation analyses and the
CFA with covariates analysis. Correlation analysis showed that aware-
ness of illness correlated positively with hospitalization and negatively
with schizophrenia spectrum diagnosis. Being hospitalized associated
with higher awareness of illness. Having a schizophrenia spectrum di-
agnosis also associated with lower awareness of illness. Age, gender,
and other diagnosis were not related with awareness of illness. Need for
treatment correlated positively with age, schizophrenia, and mood
disorders diagnoses. Therefore, older age, schizophrenia, and mood
disorders diagnoses associated with higher recognition of need for
treatment. Hospitalization was associated with the recognition of
higher need for treatment.
In a multivariate analysis, the predictors of the two insight factors
with CFA with covariates model were tested. Covariates were gender,
age, and hospitalization. Because previous analysis found associations
between insight and diagnosis, here the impact of diagnosis was con-
trolled for. Only hospitalization significantly predicted the awareness of
illness (i.e., those patients who were previously hospitalized were more
aware of their illness) (unstandardized B = 0.324; SE = 0.142,
β = 0.254 p < 0.05).
The impact of insight on shame and stigma
In order to estimate the impact of insight on shame and stigma, the
correlation matrix between the two latent factors and four factors of the
Self-Stigma of Mental Illness Scale and the shame score were estimated.
The awareness of illness factor correlated significantly with the score of
internalized stigma in self-identity (r = 0.34 p < 0.001), the score
assessing the self-esteem reduction due to stigma (r = 0.36,
p < 0.001), and the shame score (r=0.53 p < 0.001). The awareness
of illness factor did not correlate with the awareness of stigmatic views
and the agreement with stigmatic views (r = 0.11 and 0.04, respec-
tively). The need for treatment factor did not correlate with the four
factors of stigma or with the shame score.
A multivariate model within a structural equation modeling fra-
mework was tested (see Fig. 2). In this model the paths between the
need for treatment and the outcome variables were fixed to zero due to
the lack of bivariate correlations. Age and gender were controlled for in
the analysis. The awareness of illness factor significantly predicted
shame (β = 0.36, p < 0.001), internalized stigma (β = 0.27,
p < 0.01), and self-esteem reduction (β = 0.25, p < 0.01), therefore
they had unique shared variance with awareness of illness.
Discussion
The main goal of the present study was to examine the factor
structure of the Birchwood Insight Scale (BIS) among non-English
speaking individuals with different psychiatric diagnoses. The study
results indicated that the two-factor structure have the best fit and– if
not the poor functioning of Item 1 – also validates the factor structure
which was reported originally (Birchwood et al., 1994). While the
previous validation study of Cleary et al. (2014) also reported on the
poor functioning of Item 1 their findings of a one-factor structure are in
contrast to the present study's results and the original study of
Birchwood et al. (1994). Furthermore, by including different diagnostic
groups, the present study confirms the applicability of the BIS not only
among patients with psychosis but also among patients with a wider
range of diagnoses. This is also supported by the measurement in-
variance testing between patients having or not having a schizophrenia
diagnosis.
Further studies should consider the elimination of Item 1 from the
BIS or adding a new item to the ‘re-labeling symptoms’ subscale so the
scale will reflect the three known insight dimensions which have been
reported in the literature (David, 1990). Cleary et al. (2014) proposed
that the poor functioning of Item 1 might be because of the confusing
meaning of the words “made by my mind” which can have different
meanings in different cultures and can be open to different interpreta-
tions by the participants. Other sources for difficulties in interpretation
might be related to the words “some of my symptoms” and not “all of
my symptoms” (Cleary et al., 2014). As none of these options were
tested, studies should consider all these options when using the scale.
As part of examining insight among the wider patient population
groups, the present study also compared the different diagnostic groups
in terms of their insight levels. The group comparison revealed that
schizophrenia spectrum disorder patients had the lowest level of
awareness of illness compared to the mood disorders, stress-related
disorders, and other disorder group. The effect sizes were medium-sized
when schizophrenia spectrum disorders were compared with mood
disorders and stress-related disorders. However, the effect size of the
difference between patients with mood disorder and stress-related di-
agnosis were small. The mood disorders group had the highest illness
awareness. This finding is in contrast with a study indicating that stress-
related disorders patients had higher insight compared to bipolar pa-
tients and patients with depression (Ghaemi et al., 2000), and supports
the need to examine insight among individuals with different and less
severe mental illness diagnoses, especially because such research is
lacking. The finding that schizophrenia spectrum disorder patients had
Table 2
Fit indices of the alternative measurement models of the Birchwood Insight Scale.
χ2 Df p CFI TLI RMSEA Cfit of RMSEA
Model 1 One-factor model (8 items) 30.1 20 0.0675 0.973 0.962 0.050 0.465
Model 2 Three-factor model (8 items) 18.6 17 0.3538 0.996 0.993 0.021 0.794
Model 3 One-factor model (7 items)a 25.3 14 0.0320 0.970 0.955 0.063 0.259
Model 4 Two-factor model (7 items)a 15.0 13 0.3059 0.995 0.991 0.028 0.709
Multigroup analysis: Invariance testing of the two factor modelb
Configural invariance (freely estimated factor loadings and thresholds) 29.3 26 0.2991 0.992 0.987 0.036 0.612
Metric invariance model (equal factor loadings)c 30.9 31 0.4702 1.000 1.000 0.000 0.784
Scalar invariance (equal factor loadings, and equal thresholds)d 39.7 36 0.3079 0.991 0.989 0.032 0.673
Note: N = 200.
a Item 1 was removed due to non-significant factor loading. Comparison of model fit of Model 3 and Model 4 was performed with difftest procedure implemented
in Mplus 8.1. Model 4 yielded significantly closer fit to the data (Δχ2 = 6.73, Δdf = 1, p < 0.01).
b The grouping variable was having or not having schizophrenia diagnosis.
c The difftest between configural and metric invariance model is nonsignificant (Δχ2 = 2.95, Δdf = 5, p = 0.7074).
d The difftest between metric and scalar invariance model is nonsignificant ([Δχ2 = 10.25, Δdf = 5, p = 0.0685]).
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the lowest illness awareness levels is in line with other research in-
dicating that schizophrenia patients specifically have poorer awareness
of having mental illness compared to other mental disorders (Amador
et al., 1994; Braw et al., 2012; Pini et al., 2001; Ramachandran et al.,
2016), but in contrast with David et al. (1995) who found that the di-
agnosis of schizophrenia is not specifically associated with poor insight,
and with Arduini et al. (2003) who found no significant differences in
illness awareness when comparing schizophrenia and bipolar patients.
The discordant findings across studies regarding the different di-
agnoses probably depend on how the researchers operationalized the
insight measure. A frequently used way of assessing insight is based on
expert rating such as the Scale to Assess Unawareness of Mental
Disorder (SUMD; Amador et al., 1994). However, the method in the
present study was based on patients' self-report. It is important to note
that the present study supported the sensitivity to assess lower insight
in schizophrenia with self-report, which is a more cost-effective way to
assess insight compared to structured diagnostic interviews. Never-
theless, and regardless of group comparisons, schizophrenia spectrum
disorders in the present study were found to be significantly associated
with low illness awareness, which emphasizes that schizophrenia pa-
tients are sensitive and prone to deficiencies in their awareness of
having mental illness. This finding supports existing knowledge con-
cerning illness manifestations which describe poor insight as the main
illness feature (Cuesta & Peralta, 1994), with 50%–80% of patients
experiencing insight deficits to differing degrees (Amador & Gorman,
1998).
In contrast with illness awareness, schizophrenia patients did not
differ significantly from mood disorder and stress-related disorder pa-
tients in the need for treatment factor which might imply that their
awareness in terms of need for treatment is not lower than other di-
agnoses. In fact, schizophrenia patients had the highest awareness in
the need for treatment, a finding which in a larger sample and more
powered study might have reached a statistically significant level. This
finding is in line with the different manifestations of the disorders and
the continuous need for treatment control which exists – especially
among schizophrenia spectrum disorders (American Psychiatric
Association, 2006) compared to other disorders. Interestingly, while
these patients appear to be the most aware of the need for treatment,
treatment non-compliance is highest among this patient group (Cramer
& Rosenheck, 1998; Sajatovic et al., 2010), which might imply that it is
not necessarily the lack of awareness leading them not comply to
treatment, but that there might be other underlying factors. However,
considering the discordant findings across studies, more research in
needed to clarify differences in insight between patients with different
diagnoses, especially because studies examining different insight di-
mensions are lacking.
The present study also examines the possible predictors of insight
and its different consequences. From the study results it appears that
socio-demographic factors such as age and gender are not significant
predictors of insight. These results are in line with previous studies
(David et al., 1992; Goldberg et al., 2001; Marková & Berrios, 1992;
McEvoy et al., 1981). On the other hand, patients' previous hospitali-
zations found to be an important factor in the prediction of insight as it
significantly predicted illness awareness. This finding is in accord with
previous studies which found positive associations between hospitali-
zation and insight (e.g., Tariku et al., 2019) because hospitalization
may provide opportunity for the patients to learn about their specific
condition and diagnosis. However, the patients included in the present
study were stable and already under treatment, therefore this result is
not applicable for those patients who are unstable and who are
chronically hospitalized (Harvey et al., 2013). However, interesting to
note that while the presence of previous hospitalizations predicted in-
sight in terms of awareness into the illness, it did not predict patients'
awareness in the need for treatment. It is important to mention that this
finding might be the result of multicollinearity among the different
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positively associated with awareness for the need for treatment, an
association which disappeared in the multivariate analysis. However,
this association was weak to moderate in size. Still, this finding is im-
portant to consider for further research, because it implies the opposite
to the commonsense perception of being hospitalized in order to receive
a treatment, and thus might mean that hospitalizations in the context of
mental health might be more meaningful to patients' self-definition and
to an illness identity, rather than to their perception of receiving ne-
cessary treatment.
This possibility is in line with findings from stigma research, stating
that the acknowledgement of having a mental illness is associated with
negative self-definition such as perceiving the whole self and one's
identity as ill and ruined (Yanos et al., 2010), rather than, for instance,
perceiving the disorder as separate from the self, as a health condition
that might be controlled by proper treatment. Williams (2008) claims
that having the awareness that one has mental illness often initiates a
process which changes the way individuals perceive themselves,
leading them to adopt a new identity. Unfortunately, this new identity,
in many instances, appears to be affected by mental illness stigma, in-
corporating negative stereotypes which exist in the society.
The results of the present study regarding the consequences of
insight further support the possibility that illness awareness is accom-
panied by negative interpretations, because the only insight aspect
which predicted negative outcomes was the awareness of having a
mental illness, and not the recognition of the need for treatment. In fact,
the awareness of having a mental illness was found to have a negative
impact most specifically on self-related aspects, and predicted higher
internalized stigma and lower self-esteem. This was not associated with
the other lesser self-related stigma aspects, such as awareness to social
stigma and agreement with the stigma. Similarly, having a higher
awareness of the illness also predicted higher experience of shame.
These findings reinforce the accumulating studies reporting on an “in-
sight paradox”, meaning that having insight into one's illness is not
always positive, and in the context of mental illness, it might even be
detrimental. It might be present in particularly societies where espe-
cially high stigma is present, such as Hungary, because high and per-
sistent stigmatization has been reported in Hungarian society towards
mental patients (Buchman-Wildbaum et al., 2018).
Among the insight aspects, the present study targeted the “aware-
ness of having mental illness”, because this insight aspect is potentially
hurtful having negative aspects. These findings reinforce previous stu-
dies reporting the same conclusion. Using the BIS Norman et al. (2011)
found the illness awareness aspect to be the only insight aspect which
was consistently associated with depression, anxiety, anger, hostility,
and engulfment (a process describing one's acceptance of the patient
role as their main self-definition). Similarly, Hasson-Ohayon et al.
(2012) found illness awareness was the only insight aspect to be related
to higher feelings of shame. Staring et al. (2009) reported more specific
differentiation between the insight aspects in terms of their individual
contribution to different negative outcomes. In their sample, among
individuals with high internalized stigma, the awareness of having
mental illness was found to have the most influential impact on nega-
tive self-esteem, while the need for treatment aspect was found to have
the largest negative impact on depressed mood and quality of life.
Because treatment for mental illness mainly includes medication,
which often has an element of chronicity, involves limitations, and
requires adaptations, it is plausible to speculate that awareness to the
need for treatment will mainly influence individual's mood and quality
Fig. 1. Comparison of two insight factors across mental conditions.
Note: Factor scores are estimated from the CFA model. CI = confidence interval.
Table 4
Predictors of the two factors of insight: CFA with covariates analysis.
Awareness of illness Need for treatment
r β r β
Age −0.076 −0.099 0.175⁎ 0.104
Gender −0.047 −0.069 −0.020 −0.020
Hospitalization 0.199⁎⁎ 0.254⁎ 0.208⁎⁎ 0.135
R2 8.7% 10.7%
Note: N = 191. r = bivariate correlations between factor scores and the ex-
planatory variables. Hospitalization coding: 1 = hospitalized and 0 = non-
hospitalized. Diagnoses were controlled for in the model. β = standardized
regression coefficients. Boldfaced coefficients are significant at p < 0.05.
⁎ p < 0.05.
⁎⁎ p < 0.01.
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of life, and will be less related to stable beliefs of self-worth, self-defi-
nition, or self-esteem per se. However, further study is needed in order
to shed light on the complexity of the insight construct and to draw
more solid conclusions, especially as studies focusing on its specific
aspects are limited.
The results of the present study have several clinical implications.
Firstly, the study results, consistent with other findings, might imply
that in the mental health field, insight and internalized stigma might be
two intertwined factors that together produce negative consequences.
Besides the aforementioned negative effects on individual's self-per-
ception, internalized stigma has also been related to treatment non-
compliance (Gerlinger et al., 2013; Kamaradova et al., 2016), a wide-
spread problem within the mental health field, which can have severe
consequences (Lacro et al., 2002; Sajatovic et al., 2004). Therefore,
paradoxically, it might be that in some cases, having high awareness
into the illness, will interfere with patients' willingness to ask for help
and engage in treatment, although they might be aware of the need for
treatment.
Consequently, although not examined in this study, rather than
assuming full responsibility to lack of insight, internalized stigma
should be taken into consideration when facing difficulties with treat-
ment compliance. The experience of shame should also be addressed,
especially as it might make individuals more vulnerable to the inter-
nalization of stigma (Hasson-Ohayon et al., 2012). As such, this mainly
implies that there is a need to formulate intervention programs which
will aspire to improve insight while empowering patients simulta-
neously, in a way that their awareness of having a mental illness will
not be accompanied with negative self-definition.
Psychoeducation programs which supply knowledge concerning
mental illness, the treatment, and focus on refuting stereotypes might
be helpful. However, the impact of such programs on insight remains
unclear. There is evidence that these programs increase knowledge
(Lincoln et al., 2007b) but it is not clear if the patients use such
knowledge in their everyday life and struggles (Kemp & David, 1995;
Sevy et al., 2004). A promising intervention which was found to in-
crease insight (Yanos et al., 2012) and reduce internalized stigma
(Hansson et al., 2017) is Narrative Enhancement and Cognitive Therapy
(NECT) (Yanos et al., 2011). Intervention programs aiming to increase
insight should keep in mind that although having awareness to any life
struggle is an important step in recovery, in the mental health field, not
only might this not be enough, but it might also be contaminated with
stigmatic and self-devaluing beliefs. Therefore, internalized stigma and
shameful feelings should be an inseparable part of any intervention or
treatment plan offered to individuals coping with mental illness.
Secondly, the study results may also stress the need to examine and
address insight among patients with different diagnoses instead of fo-
cusing solely on those with schizophrenia. While the BIS in this study
was found to be applicable to patients with different diagnoses, future
research might benefit from the development of insight scales which are
tailored to specific diagnoses. A promising step in this direction is the
Mood Disorders Insight Scale (MDIS), a modified version of the BIS, that
is suitable specifically for mood disorders (Sturman & Sproule, 2003).
Third, the present study stresses the complexity of insight and the
need to differentiate between different aspects of insight. As such, ef-
forts to increase awareness of the illness itself without taking special
care, might not always be the best practice, especially among in-
dividuals who are affected by stigma. On the other hand, the fact that
awareness concerning the need for treatment was not associated with
stigma or shame, might be highly informative for clinicians and for the
development of intervention programs aimed at improving treatment
compliance. However, as previous studies (i.e., Staring et al., 2009)
reported that awareness concerning the need for treatment can be as-
sociated with other negative consequences (which were not examined
in this study), additional research is needed, especially because studies
examining the different aspects of insight and their outcomes are
lacking.
The present study also has several limitations. First, since a wide
range of diagnoses were included in the study for simplification pur-
poses, patients with different diagnoses were grouped together into a
larger diagnostic category. This compromised the ability of this study to
identify differences which might exist between patients in the same
groups. Future studies should examine insight in more specific diag-
nostic groups, and among a larger sample. Second, a convenience
sample used in the present study which also compromises the gen-
eralization of the results to the wider population. Third, because the
study was cross-sectional, causality between variables cannot be in-
ferred. Moreover, because insight can fluctuate over time (Wiffen et al.,
2010), longitudinal studies are especially needed. Finally, as cultural
differences exist in stigma towards mental illness (Abdullah & Brown,



































Fig. 2. Structural equation modeling of insight, internalized stigma and shame.
Note: Only the significant (p < 0.05) paths are presented. The path coefficients and factor loadings are standardized.
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on the impact of insight and its relatedness to internalized stigma and
negative outcomes.
Conclusions
Despite the limitations, the present study contributes important
knowledge concerning the study of insight in the psychiatric field. The
results support the construct of insight and also the use of the BIS
among non-English speaking patients with different diagnoses. In
clinical practice, practitioners should keep in mind that poor insight
might be commonplace among patients with different psychiatric di-
agnoses, and is not just limited to patients with schizophrenia.
Therefore, efforts to increase insight should be directed towards dif-
ferent patient populations, including schizophrenia patients. However,
these efforts should be implemented cautiously, with careful con-
sideration of stigma, and the negative meaning it has for individuals
coping with mental illnesses. Further research is needed to better un-
derstand the complexity of insight and how its promotion can be di-
rected towards individual growth and recovery.
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